Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Royal Maxim Palace Kempinski

Oct 14, 2019 8:00 AM - Oct 15, 2019 5:00 PM

1st Settlement, Eastern Ring Road, New Cairo, 11477, Egypt

DIA Pharmacovigilance Workshop (Middle East & Africa Region)

Keeping up-to-date with the pharmacovigilance landscape in MENA region.

Session 7: MERC Pharmacovigilance Session

Session Chair(s)

Reem K Al Essa, MBA

Reem K Al Essa, MBA

Coordination & Development Superintendent Pharmaceutical Services Administration

Ministry of Health, Kuwait

Hadir  Rostom

Hadir Rostom

Head, Egyptian Pharmaceutical Vigilance Center (EPVC)

Pharmaceutical Affairs Central Administration (CAPA), Ministry of Health, Egypt, Egypt

Session 7: MERC Pharmacovigilance Session

Speaker(s)

Sean  Burke, MSc

Sean Burke, MSc

Merck , United Kingdom

(EFPIA IPVG Representative) Pharmacovigilance Lead, EEMEA

Phil  Tregunno

Phil Tregunno

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Deputy Director - Patient Safety Monitoring

Shanthi  Pal, DrSc, MPharm

The “Project 3-S”: Smart Safety Surveillance for priority medical products

Shanthi Pal, DrSc, MPharm

WHO, Switzerland

Group Lead, Medicines Safety, Safety & Vigilance

Mohammed Ebrahim Fouda, PharmD, RPh

The SFDA Experience – Moving to the Investigation Phase

Mohammed Ebrahim Fouda, PharmD, RPh

Saudi Food and Drug Authority (SFDA), Saudi Arabia

Head of Signal Detection Department

Reem K Al Essa, MBA

Kuwait’s Roadmap on Pharmacovigilance

Reem K Al Essa, MBA

Ministry of Health, Kuwait

Coordination & Development Superintendent Pharmaceutical Services Administration

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.